イオン性液体の毒性評価:アセチルコリネステラゼ酵素阻害のためのQSARアプローチ
Ali Ebrahimpoor Gorji1, Petri Uusi-Kyyny1, Ville Alopaeus1
1School of Chemical Technology, Department of Chemical and Metallurgical Engineering, Research Group of Chemical Engineering, Aalto University, P.O. Box 16100, FI-00076 Aalto, Finland.
Chemical research in toxicology
|February 17, 2026
まとめ
新しい定量的な構造-活性関係 (QSAR) モデルは,アセチルコリネステラーゼ (AChE) 阻害を分析することによって,イオン液 (IL) 毒性を予測します. この堅牢なモデルは,11個の量子化学記述子を用いて,アニオン効果を含むIL毒性を正確に予測します.
科学分野:
- 環境化学 環境化学
- 毒理学 毒理学 毒理学
- コンピューティング・ケミストリー
背景:
- イオン性液体 (ILs) は,潜在的な環境影響を持つ多用途溶剤です.
- ILの毒性を予測することは,安全な適用のために非常に重要です.
- 既存のモデルでは,アニオン構造が毒性に影響することをしばしば見過ごしている.
研究 の 目的:
- ILの毒性を予測するための堅牢な定量構造-活性関係 (QSAR) モデルを開発する.
- ILの毒性に影響を与える主要な分子記述者を特定する.
- アセチルコリネステラーゼ (AChE) 酵素活性に対するILの影響の予測を改善するために.
主な方法:
- 243 IL のデータセットをまとめ,トレーニングとテストセットに分けました.
- 最適な分子記述者を選択するために,ブレイクポイント分析を行いました.
- 11つのCOSMO-RS量子化学記述子を用いた多重線形回帰 (MLR) モデルを開発した.
- 内部 (クロス検証) と外部 (テストセット) の方法を使用してモデルを検証しました.
主要な成果:
- MLR-QSARモデルは高い内部検証を達成しました (Q2LOO=0.79,Q2LMO=0.78).
- 外部検証により,強力な予測性能 (R2=0.75,RMSE=0.35) が示されました.
- このモデルは,カチオンとアニオンの両方の特徴を効果的に組み込み,以前の研究を上回った.
結論:
- 開発されたMLR-QSARモデルは,ILの毒性を予測するのに統計的に信頼性があります.
- このモデルは,ILの毒性に対する構造的貢献に関するメカニズム的洞察を提供します.
- この研究は,ILの安全プロファイルの理解を向上させ,より安全なILを設計するのに役立ちます.
さらに関連する動画
関連する概念動画
Anticholinesterase Agents: Poisoning and Treatment
1.7K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.7K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.0K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.0K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.8K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.9K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.9K
Toxic Reactions: Overview
2.4K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
2.4K
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
1.7K
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.7K


